中南大学 Zeng Zhaoyang

Language : English

曾朝阳

Home

Journal Publications

Research Projects

Books

Patents

Teaching

Honors and Awards

Recommended Ph.D.Supervisor
Recommended MA Supervisor

MOBILE Version

Journal Publications

Current position: Home > Journal Publications

[1]Zhi Y#, Wang Q#, Zi M#, Zhang S, Ge J, Liu K, Lu L, Fan C, Yan Q, Shi L, Chen P, Fan S, Liao Q, Guo C, Wang F, Gong Z*, Xiong W*, Zeng Z*. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment.Adv Sci. 2024 Jan 16:e2306515
[2]Wang J, Ge J, Wang Y, Xiong F, Guo J, Jiang X, Zhang L, Deng X, Gong Z, Zhang S, Yan Q, He Y, Li X, Shi L, Guo C, Wang F, Li Z, Zhou M, Xiang B, Li Y, Xiong W*, Zeng Z*. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1.Nat Commun. 2022 Feb 14; 13(1): 866.
[3]Jiang X, Deng X, Wang J, Mo Y, Shi L, Wei F, Zhang S, Gong Z, He Y, Xiong F, Wang Y, Guo C, Xiang B, Zhou M, Liao Q, Li X, Li Y, Li G, Xiong W, Zeng Z*. BPIFB1 inhibits vasculogenic mimicry via downregulation of GLUT1-mediated H3K27 acetylation in nasopharyngeal carcinoma.Oncogene. 2022 Jan; 41(2):233-245.
[4]Ge J, Wang J, Xiong F, Jiang X, Zhu K, Wang Y, Mo Y, Gong Z, Zhang S, He Y, Li X, Shi L, Guo C, Wang F, Zhou M, Xiang B, Li Y, Li G, Xiong W, Zeng Z*. Epstein-Barr Virus-Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1.Cancer Res. 2021 Oct 1; 81(19):5074-5088.
[5]Tang L, Xiong W, Zhang L, Wang D, Wang Y, Wu Y, Wei F, Mo Y, Hou X, Shi L, Xiong F, Zhang S, Gong Z, Liao Q, Xiang B, Zhang W, Zhou M, Li X, Li G, Guo C, Zeng Z*. circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma.Oncogene. 2021 Jan; 40(2):307-321.
[6]Fan C, Qu H, Xiong F, Tang Y, Tang T, Zhang L, Mo Y, Li X, Guo C, Zhang S, Gong Z, Li Z, Xiang B, Deng H, Zhou M, Liao Q, Zhou Y, Li X, Li Y, Li G, Wang F*, Zeng Z*. CircARHGAP12 promotes nasopharyngeal carcinoma migration and invasion via ezrin-mediated cytoskeletal remodeling.Cancer Lett. 2021 Jan 1; 496: 41-56.
[7]Zhao J, Guo C, Xiong F, Yu J, Ge J, Wang H, Liao Q, Zhou Y, Gong Q, Xiang B, Zhou M, Li X, Li G, Xiong W*, Fang J*, Zeng Z*. Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal cancer.Cancer Lett. 2020 May 1; 477: 131-143.
[8]Fan CM, Wang JP, Tang YY, Zhao J, He SY, Xiong F, Guo C, Xiang B, Zhou M, Li XL, Li Y, Li GY, Xiong W*, Zeng ZY*. circMAN1A2 could serve as a novel serum biomarker for malignant tumors.Cancer Sci. 2019 Jul; 110(7): 2180-2188.
[9]Wei F, Tang L, He Y, Wu Y, Shi L, Xiong F, Gong Z, Guo C, Li X, Liao Q, Zhang W, Ni Q, Luo J, Li X, Li Y, Peng C, Chen X, Li G, Xiong W*, Zeng Z*. BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression.Cell Death Dis. 2018 Mar 22; 9(4): 432.
[10]Wei F, Wu Y, Tang L, He Y, Shi L, Xiong F, Gong Z, Guo C, Li X, Liao Q, Zhang W, Zhou M, Xiang B, Li X, Li Y, Li G, Xiong W*, Zeng Z*. BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.Br J Cancer. 2018 Jan;118(2):233-247.

total10 1/1

firstpreviousnextlast